Medeor Therapeutics
Medeor Therapeutics is a biotechnology company developing personalized cellular immunotherapies to improve health outcomes of patients receiving organ transplants.
1
Funding Rounds
$57.0m
Money raised
Funding series
Funding Series Analysis
The company Medeor Therapeutics has raised a total of $57m in funding over 1 rounds.
Key Insights:
- Medeor Therapeutics Series B round, November 2017: $57m
Medeor Therapeutics Series B round, November 2017
$57m
Industries
Medeor Therapeutics is active in the following industries: